The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCBX.L Regulatory News (CBX)

  • There is currently no data for CBX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Extension of option agreements

13 Jul 2007 07:30

Cubus Lux plc Extension of options to acquire certain development land known as the Olive Island Resort

On 13 March 2007, Cubus Lux plc (the "Company") announced that it had entered into two option agreements to acquire certain development land known as the "Olive Island Resort" on the coast of Dalmatia in Croatia. These options were originally for a four month term, expiring on 12 July 2007.

The Company entered into agreements on 12 July 2007 to extend these options for a further two months, expiring on 12 September 2007.

The Olive Island Resort development land is intended to be developed into a village resort comprising 126 villas and 305 apartments as well as accompanying facilities, such as restaurants, shops, offices and a marina (the "Villas Development"); and a four-star hotel containing 500 beds (the "Hotel Development").

Both option agreements are conditional upon a number of factors, including completion of due diligence by the Company, finalisation of the terms of acquisition and the raising of debt or equity financing by the Company for at least ¢â€š¬10 million. The exercise of the options is subject to appropriate consents having been granted by the government of Croatia.

Highlights, as announced on 13 March 2007:

* Option to acquire the Villas Development for ¢â€š¬10 million in cash and the issue of 33 million ordinary shares in the Company.

* Option to acquire the Hotel Development for ¢â€š¬5 million in ordinary shares of the Company.

* Independent valuation by UK based surveyors Kings Sturge of the Villas Development at ¢â€š¬39 million and the Hotel Development at ¢â€š¬5 million.

In the event that the Company proceeds with the acquisition of the Villas Development and the Hotel Development, the transaction is expected to constitute a reverse takeover for the purposes of the AIM Rules, and will therefore require the issue of an admission document and shareholder approval. In addition, the transaction would be considered to be a related party transaction for the purposes of the AIM Rules due to the connection between Gerhard Huber, Michael Janssen and Christian Kaiser (directors of the Company) and the counterparties to the option agreements.

For further information please contact:

Leon Nahon +44 (0)7920 834 156Cubus Lux plcRoss Andrews/Simon Sacerdoti +44 (0)20 7090 7800City Financial Associates LimitedGraham Herring/Josh Royston +44 (0)20 7936 9605Threadneedle Communications Limited

CUBUS LUX PLC
Date   Source Headline
23rd Dec 20227:00 amRNSTR-1: Standard notification of major holdings
23rd Dec 20227:00 amRNSCellular Goods Annual Results
23rd Nov 20226:16 pmRNSTR-1: Standard notification of major holdings
2nd Nov 202210:34 amRNSTR-1: Standard notification of major holdings
24th Oct 20227:00 amRNSProducts launch on Debenhams.com
20th Oct 20227:00 amRNSLaunch of gift set collection for festive season
26th Sep 20227:00 amRNSProposed purchase of Cannaray Brands and Love CBD
23rd Sep 20225:49 pmRNSTR-1: Standard notification of major holdings
23rd Sep 20225:47 pmRNSTR-1: Standard notification of major holdings
23rd Sep 20225:42 pmRNSTR-1: Standard notification of major holdings
23rd Sep 20227:00 amRNSCellular Goods now shipping products to the USA
23rd Sep 20227:00 amRNSCellular Goods now shipping products to the USA
21st Sep 20222:06 pmRNSSecond Price Monitoring Extn
21st Sep 20222:00 pmRNSPrice Monitoring Extension
21st Sep 20227:00 amRNSLaunch of three new skincare products
6th Sep 20227:00 amRNSPublication of new white paper
17th Aug 20227:00 amRNSGrant of Share Options
16th Aug 20227:00 amRNSAppointment of new Chief Financial Officer
5th Aug 20224:40 pmRNSSecond Price Monitoring Extn
5th Aug 20224:35 pmRNSPrice Monitoring Extension
4th Aug 20229:05 amRNSSecond Price Monitoring Extn
4th Aug 20229:00 amRNSPrice Monitoring Extension
3rd Aug 20224:41 pmRNSSecond Price Monitoring Extn
3rd Aug 20224:35 pmRNSPrice Monitoring Extension
3rd Aug 20229:05 amRNSSecond Price Monitoring Extn
3rd Aug 20229:00 amRNSPrice Monitoring Extension
2nd Aug 20224:40 pmRNSSecond Price Monitoring Extn
2nd Aug 20224:35 pmRNSPrice Monitoring Extension
2nd Aug 202211:05 amRNSSecond Price Monitoring Extn
2nd Aug 202211:00 amRNSPrice Monitoring Extension
1st Aug 20222:00 pmRNSPrice Monitoring Extension
13th Jul 20227:00 amRNSUpdate on marketing initiatives and YouGov survey
11th Jul 20227:00 amRNSLaunch of minis
20th Jun 20227:00 amRNSLaunch of CBG and CBD petition
30th May 20227:00 amRNSInterim results
20th May 20227:00 amRNSTR-1: Standard notification of major holdings
20th May 20227:00 amRNSTR-1: Standard notification of major holdings
16th May 20222:05 pmRNSSecond Price Monitoring Extn
16th May 20222:00 pmRNSPrice Monitoring Extension
12th May 20227:00 amRNSBoard changes
28th Apr 20227:00 amRNSInvestor presentation
28th Apr 20227:00 amRNSFirst patent application filed
22nd Apr 20226:04 pmRNSUpdate on ingestibles product range
22nd Apr 20227:00 amRNSWhite paper on lab-produced cannabinoids
13th Apr 20227:00 amRNSUpdate on ingestibles product range
11th Apr 20227:00 amRNSUpdate on ingestibles products
7th Apr 202210:24 amRNSTR-1: Standard notification of major holdings
1st Apr 20222:05 pmRNSSecond Price Monitoring Extn
1st Apr 20222:00 pmRNSPrice Monitoring Extension
28th Mar 20224:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.